Thompson Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.74M | Buy |
34,736
+2,929
| +9% | +$630K | 1% | 35 |
|
|
2026
Q1 | $6.92M | Buy |
31,807
+99
| +0.3% | +$22K | 0.89% | 45 |
|
|
2025
Q4 | $7.24M | Sell |
31,708
-276
| -0.9% | -$62.9K | 0.91% | 38 |
|
|
2025
Q3 | $7.41M | Sell |
31,984
-781
| -2% | -$159K | 0.99% | 37 |
|
|
2025
Q2 | $6.08M | Sell |
32,765
-378
| -1% | -$70.3K | 0.86% | 46 |
|
|
2025
Q1 | $6.94M | Sell |
33,143
-5,362
| -14% | -$1.04M | 1.04% | 36 |
|
|
2024
Q4 | $6.84M | Sell |
38,505
-508
| -1% | -$93.4K | 0.98% | 37 |
|
|
2024
Q3 | $7.7M | Buy |
39,013
+187
| +0.5% | +$34.9K | 1.1% | 36 |
|
|
2024
Q2 | $6.66M | Sell |
38,826
-115
| -0.3% | -$19.1K | 1.03% | 36 |
|
|
2024
Q1 | $7.09M | Sell |
38,941
-367
| -0.9% | -$63.3K | 1.07% | 36 |
|
|
2023
Q4 | $6.09M | Sell |
39,308
-397
| -1% | -$57.9K | 0.98% | 39 |
|
|
2023
Q3 | $5.92M | Sell |
39,705
-581
| -1% | -$85.3K | 1.05% | 37 |
|
|
2023
Q2 | $5.43M | Buy |
40,286
+2,084
| +5% | +$306K | 0.88% | 42 |
|
|
2023
Q1 | $6.09M | Sell |
38,202
-1,393
| -4% | -$213K | 1.03% | 35 |
|
|
2022
Q4 | $6.4M | Sell |
39,595
-1,486
| -4% | -$228K | 1.17% | 28 |
|
|
2022
Q3 | $5.51M | Sell |
41,081
-2,203
| -5% | -$316K | 1.07% | 32 |
|
|
2022
Q2 | $6.63M | Sell |
43,284
-4,160
| -9% | -$636K | 1.15% | 26 |
|
|
2022
Q1 | $7.69M | Sell |
47,444
-4,315
| -8% | -$627K | 1.13% | 30 |
|
|
2021
Q4 | $7.01M | Sell |
51,759
-6,164
| -11% | -$728K | 0.99% | 34 |
|
|
2021
Q3 | $6.25M | Buy |
57,923
+977
| +2% | +$112K | 0.93% | 36 |
|
|
2021
Q2 | $6.41M | Sell |
56,946
-526
| -0.9% | -$59.2K | 0.93% | 37 |
|
|
2021
Q1 | $6.22M | Buy |
57,472
+775
| +1% | +$82.9K | 0.94% | 32 |
|
|
2020
Q4 | $6.08M | Buy |
56,697
+1,138
| +2% | +$109K | 1.03% | 29 |
|
|
2020
Q3 | $4.87M | Sell |
55,559
-2,718
| -5% | -$256K | 0.91% | 41 |
|
|
2020
Q2 | $5.72M | Sell |
58,277
-1,943
| -3% | -$171K | 1.11% | 28 |
|
|
2020
Q1 | $4.59M | Sell |
60,220
-1,696
| -3% | -$144K | 1.02% | 31 |
|
|
2019
Q4 | $5.48M | Sell |
61,916
-3,369
| -5% | -$280K | 0.89% | 39 |
|
|
2019
Q3 | $4.94M | Buy |
65,285
+1,972
| +3% | +$135K | 0.97% | 38 |
|
|
2019
Q2 | $4.6M | Buy |
63,313
+1,560
| +3% | +$123K | 0.9% | 41 |
|
|
2019
Q1 | $4.98M | Buy |
61,753
+1,050
| +2% | +$85.9K | 0.95% | 41 |
|
|
2018
Q4 | $5.6M | Sell |
60,703
-3,264
| -5% | -$287K | 1.31% | 22 |
|
|
2018
Q3 | $6.05M | Sell |
63,967
-171
| -0.3% | -$16.2K | 1.08% | 27 |
|
|
2018
Q2 | $5.94M | Buy |
64,138
+131
| +0.2% | +$12.8K | 1.08% | 28 |
|
|
2018
Q1 | $6.06M | Sell |
64,007
-5,035
| -7% | -$553K | 1.13% | 27 |
|
|
2017
Q4 | $6.68M | Sell |
69,042
-4,107
| -6% | -$387K | 1.18% | 25 |
|
|
2017
Q3 | $6.5M | Sell |
73,149
-4,415
| -6% | -$336K | 1.21% | 24 |
|
|
2017
Q2 | $5.62M | Sell |
77,564
-99
| -0.1% | -$6.66K | 1.06% | 32 |
|
|
2017
Q1 | $5.06M | Buy |
77,663
+431
| +0.6% | +$27.1K | 0.96% | 41 |
|
|
2016
Q4 | $4.84M | Buy |
77,232
+4,845
| +7% | +$296K | 0.95% | 38 |
|
|
2016
Q3 | $4.57M | Sell |
72,387
-670
| -0.9% | -$43.4K | 0.88% | 50 |
|
|
2016
Q2 | $4.52M | Buy |
73,057
+2,415
| +3% | +$147K | 0.93% | 40 |
|
|
2016
Q1 | $4.04M | Buy |
70,642
+47,423
| +204% | +$2.64M | 0.84% | 55 |
|
|
2015
Q4 | $1.38M | Buy |
23,219
+1,500
| +7% | +$86.4K | 0.29% | 85 |
|
|
2015
Q3 | $1.18M | Buy |
21,719
+18,233
| +523% | +$1.19M | 0.26% | 90 |
|
|
2015
Q2 | $234K | Sell |
3,486
-200
| -5% | -$13.1K | 0.04% | 154 |
|
|
2015
Q1 | $216K | Sell |
3,686
-300
| -8% | -$18.1K | 0.04% | 156 |
|
|
2014
Q4 | $261K | Sell |
3,986
-144
| -3% | -$9.08K | 0.05% | 149 |
|
|
2014
Q3 | $262K | Hold |
4,130
| – | – | 0.05% | 152 |
|
|
2014
Q2 | $233K | Hold |
4,130
| – | – | 0.05% | 151 |
|
|
2014
Q1 | $212K | Buy |
4,130
+300
| +8% | +$15.2K | 0.04% | 159 |
|
|
2013
Q4 | $202K | Buy |
+3,830
| New | +$188K | 0.04% | 165 |
|
Other funds holding ABBV
Thompson Investment Management's ABBV Position: Q2 2026 in Review
Thompson Investment Management increased its AbbVie (ABBV) stake by 9.2% in Q2 2026, buying an estimated $630K and bringing the position to 34,736 shares worth $8.74M. The position accounts for 1% of the portfolio, ranked #35.
Thompson Investment Management first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Thompson Investment Management held 34,736 shares of AbbVie worth $8.74M as of Q2 2026.
- Thompson Investment Management bought 2,929 AbbVie shares in Q2 2026, an estimated $630K.
- AbbVie made up 1% of Thompson Investment Management's portfolio in Q2 2026, its #35 holding.
- Thompson Investment Management first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.